Skip to main content

#151663

MEF PKCe KO KI Cell Line

Cat. #151663

MEF PKCe KO KI Cell Line

Cat. #: 151663

Unit size: 1x10^6 cells / vial

Availability: 10-12 weeks

Organism: Mouse

Tissue: Embryo

Disease: Cancer

Model: Transgenic

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Peter Parker

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: MEF PKCe KO KI Cell Line
  • Research fields: Cancer;Cell biology;Cell signaling and signal transduction
  • Organism: Mouse
  • Tissue: Embryo
  • Disease: Cancer
  • Growth properties: Normal phenotype
  • Model: Transgenic
  • Description: MEF PKCe KO KI Cell Line is a clonal MEF line derived from PKCepsilon knock-out embryos subsequently transfected to re-express PKCe through stable transfection with pcDNA3 CMV/IE hygo+ PKCe. Matched isogenic cell line which is null for PKCe is also available. Useful for studying the role of PKCe in various biological processes
  • Production details: MEFs were derived from PKCe knockout embryos. Polyclonal PKCeKO cells were transfected with pcDNA3 CMV/IE hygro+ PKCe vector using calcium phosphate. Clonal stable cell lines were selected using limiting dilution. The vector was contructed by replacing the promoter region in pCMV hygro+ with a 2.1kb CMV/IE promoter derived from p63d. Mouse cDNA encoding full-length PKCe (3.3kb fragment) was ligated to the modified pcDNA3 CMV/IE hygro+ vector.
  • Cellosaurus id: CVCL_AS82

Target Details

  • Target: PKC epsilon

Handling

  • Format: Frozen
  • Growth medium: Cells were selected, and are routinely cultured in DMEM + 10% FCS and 100ug/ml hygromycin at 30degC in a 10% CO2 atmosphere
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

References

  • Cited by 24 subsequent publications including:
  • Ivaska, J. et al. 2002. EMBO J. 21:3608-19.PMID: 12110574
  • Kermorgant, S. et al. 2004. EMBO J. 23: 3721:34. PMID 15385963
  • Pardo et al. 2006. EMBO J. 25(13):3078-88. PMID: 16810323.
  • FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.